Research

For more than 80 years, we have been researching and developing new formulas, always challenging the existing. We rethink the present to improve the future, looking after health and providing better access.

R+D

From the onset, Research & Development has been from a pillar of growth and a source of identity.

For decades, Laboratorio Elea has prioritized the development of high impact solutions under Public Private partnership models; a model that has allowed us to associate with different excellence research centers.

Learn more


Some of our most outstanding achievements:
  • Biosimilar Monoclonals Antibodies
  • Production of Recombinant Human Tyrosine-protein phosphatase protein
  • Study of the response to EPO in children and adults with AIDS under AZT treatment.
  • Recombinant Human Granulocyte Colony-stimulating factor.
  • Recombinant Human IFN-Alpha 2-a


We contribute to accessibility – Chagas (Kiss Bug) Treatment
We put out trust in contributing to accessibility, thus, we conduct the local development of Benznidazole, the molecule used for Chagas Disease treatment. We developed a new chemical synthesis process that enabled low-cost continuous manufacturing of Benznidazole. As a result, we were able to carry out, jointly with Fundación Mundo Sano (Argentina) and DnDi (Drugs for Neglected Diseases- Switzerland), several clinical trials that enabled the US FDA approval of our Benznidazole.

Learn more

We manufacture between
35 and 40 million units a year

Our Plant

We boast one of the newest, most modern production plants in Argentina. In our +90,000 mt2, we research, develop, produce and innovate from Argentina to the world, making us into one of the leading pharmaceutical laboratories in our country.

button
Expansion 2020
  • New aerosol sector.
  • Coming soon, new ophthalmic products sector.
  • Extension of the warehouse to allow for higher production capacity.

Our unique plant and our strategic alliances allow us to guarantee quality, safety and accessibility in everything we do.

Cutting-edge technology

We boast state-of-the-art technology that allows us to offer complete product lines: Monoclonal antibodies, hormonal, osmotic antibodies, respiratory MDI, DPI antibodies, nasal sprays, ophthalmic, liquid, semisolid, solid and most pharmaceutical forms.

Liquid:
Suspensions
Emulsions
Solutions

Solid:
Tablets
Osmotic tablets
Capsules:
Microgranules
Powders

Semi-solid::
Creams
Ointments
Suppositories
Ovules
Geles

Powder in Envelops
Eyewashes
Aerosols
Respiratory

Acceder
Usted está accediendo a una sección del sitio que contiene información para los profesionales de la salud

Aquí se encuentra orientación específica para el uso adecuado de los medicamentos que se obtienen bajo prescripción médica.

Ante cualquier duda sobre condiciones médicas particulares es pertinente consultar a un profesional de la salud.

Acceder Acceder

Over 1000 people who put their trust in Argentina’s Pharmaceutical Industry make up this pharmaceutical company.

We share the passion in working from the beginning of manufacturing up to the marketing of our products with a common goal in mind: people’s health. .

We are passionate in what we do.

Innovation

Innovating is to be focused on the future, without ignoring our past nor neglecting our present.
Innovating is also to actively listen to our collaborators, clients and suppliers.
We have cutting-edge technologies and a highly qualified staff to become a better version of ourselves every day.
We innovate identifying and fostering new opportunities to do things..